Article ; Online: CD40 expression in renal cell carcinoma is associated with tumor apoptosis, CD8(+) T cell frequency and patient survival.
2014 Volume 75, Issue 7, Page(s) 614–620
Abstract: The co-stimulatory molecule, CD40, is expressed in renal cell carcinoma (RCC) and a variety of inflammatory diseases in the kidney. We investigated the relationship between tumor-associated CD40 expression, immune milieu of the tumor microenvironment, ... ...
Abstract | The co-stimulatory molecule, CD40, is expressed in renal cell carcinoma (RCC) and a variety of inflammatory diseases in the kidney. We investigated the relationship between tumor-associated CD40 expression, immune milieu of the tumor microenvironment, tumor stage and survival of patients with RCC. The expression of CD40, TUNEL and CD8 in human renal cell carcinomas was analyzed by immunohistochemistry performed on tissue samples obtained at the time of surgery. Computer-assisted quantitation of protein expression was used to analyze results in connection with patient survival and tumor stage. We show for the first time that tumor-associated CD40 expression is associated with prolonged survival in RCC patients. Tumor apoptosis (TUNEL) and CD8 immunostaining were also associated with patient survival. No relation was observed between CD40 expression and tumor stage. Our results suggest CD40 may be a prognostic biomarker indicative of prolonged RCC patient survival. Strategies that up-regulate CD40 expression in some RCC patients may thus improve survival, supporting further studies of agonistic CD40 antibodies in RCC. |
---|---|
MeSH term(s) | Apoptosis ; Biomarkers, Tumor/genetics ; Biomarkers, Tumor/metabolism ; CD40 Antigens/genetics ; CD40 Antigens/metabolism ; CD8-Positive T-Lymphocytes/metabolism ; CD8-Positive T-Lymphocytes/pathology ; Carcinoma, Renal Cell/genetics ; Carcinoma, Renal Cell/metabolism ; Carcinoma, Renal Cell/mortality ; Carcinoma, Renal Cell/pathology ; Female ; Follow-Up Studies ; Gene Expression ; Humans ; In Situ Nick-End Labeling ; Kidney/metabolism ; Kidney/pathology ; Kidney Neoplasms/genetics ; Kidney Neoplasms/metabolism ; Kidney Neoplasms/mortality ; Kidney Neoplasms/pathology ; Lymphocyte Count ; Male ; Middle Aged ; Neoplasm Staging ; Prognosis ; Survival Analysis ; Tumor Microenvironment/genetics |
Chemical Substances | Biomarkers, Tumor ; CD40 Antigens |
Language | English |
Publishing date | 2014-05-04 |
Publishing country | United States |
Document type | Journal Article ; Research Support, N.I.H., Intramural |
ZDB-ID | 801524-7 |
ISSN | 1879-1166 ; 0198-8859 |
ISSN (online) | 1879-1166 |
ISSN | 0198-8859 |
DOI | 10.1016/j.humimm.2014.04.018 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 1597: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.